Charles Schwab Investment Management Inc Cardlytics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Cardlytics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 269,724 shares of CDLX stock, worth $525,961. This represents 0.0% of its overall portfolio holdings.
Number of Shares
269,724
Previous 340,694
20.83%
Holding current value
$525,961
Previous $620,000
28.23%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding CDLX
# of Institutions
102Shares Held
27.4MCall Options Held
294KPut Options Held
394K-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny5.61MShares$10.9 Million0.45% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$6.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$4.71 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY1.65MShares$3.22 Million0.21% of portfolio
-
Kps Global Asset Management Uk LTD London, X01.22MShares$2.38 Million0.38% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $64.1M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...